Investigation of a QM/MM study on interaction of a carbon nanotube with cytarabine drug in various solvents and temperatures
Source abstract
Abstract
At the present time, usage of nanotubes in medicinal science and biology is further studied. Nanotubes can pass through cell walls, transfer, and liberate drugs in particular tissues. The goal of this article is to survey the interaction of a nanotube with an anticancer drug. In this study, transferring of an anticancer drug called cytarabine with zigzag (5, 0) carbon nanotube is studied. All computations are surveyed by quantum mechanics and molecular mechanics (MM)/Monte Carlo simulation (in various force fields such as MM+, assisted model building with energy refinement, and optimized potential for liquid simulations) in various temperatures, and their results are achieved in gas phase, water solvent, and methanol solvent, respectively.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon Nanotubes in Composites · Fullerene Chemistry and Applications · Nanotechnology research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Wang WS, Tzeng CH, Chiou TJ, Liu JH, Hsieh RK, Yen CC, Chen PM: High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Jpn. J. Clin. Oncol. 1997,27(3):154–157. 10.1093/jjco/27.3.15410.1093/jjco/27.3.154 ↗
2. Ogbomo H, Michaelis M, Klassert D, Doerr HW, Cinatl J: Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer Cell lysis of leukemic cells. Neoplasia 2008,10(12):1402–1410.10.1593/neo.08972 ↗
3. Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J: Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia: French Chronic Myeloid Leukemia Study Group. N. Engl. J. Med. 1997, 337: 223–229. 10.1056/NEJM19970724337040210.1056/NEJM199707243370402 ↗
4. Baccarani M, Rosti G, de Vivo A, Bonifazi F, Russo D, Martinelli G, Testoni N, Amabile M, Fiacchini M, Montefusco E, Saglio G, Tura S: A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia. Blood 2002, 99: 1527–1535. 10.1182/blood.V99.5.152710.1182/blood.V99.5.1527 ↗
5. Capizzi RL, White JC, Powell BL, Perrino F: Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Semin. Hematol. 1991,28(3 Suppl 4):54–69.
6. Iijima S: Helical microtubules of graphitic carbon. Nature 1991, 354: 56–58. 10.1038/354056a010.1038/354056a0 ↗
7. Collins PG, Zettle A, Bando H, Smalley RE: Nanotube nanodevice. Science 1997, 278: 100–103. 10.1126/science.278.5335.10010.1126/science.278.5335.100 ↗
8. Liu JZ, Zheng QS, Wang LF, Jiang Q: Mechanical properties of single walled carbon nanotube bundles as bulk materials. J Mech Phys Solids. 2005, 53: 123–142. 10.1016/j.jmps.2004.06.00810.1016/j.jmps.2004.06.008 ↗
9. Bianco A, Kostarelos K, Partidos CD, Prato M: Biomedical applications of functionalized carbon nanotubes. Chem. Commun. 2005, 5: 571–577.10.1039/b410943k ↗
10. Balasubramanian K, Burghard M: Chemically functionalized carbon nanotubes. Small 2005, 2: 92–180.
11. Harrison BS, Atala A: Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28: 344–53. 10.1016/j.biomaterials.2006.07.04410.1016/j.biomaterials.2006.07.044 ↗
12. Chen X, Kis A, Zettl A, Bertozzi CR: A cell nanoinjector based on carbon nanotubes. Proc. Natl. Acad. Sci. 2007, 104: 8218–8222. 10.1073/pnas.070056710410.1073/pnas.0700567104 ↗
13. Bianco A: Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Delivery 2004, 1: 57–65. 10.1517/17425247.1.1.5710.1517/17425247.1.1.57 ↗
14. Yang R, Yang X, Zhang Z, Zhang Y, Wang S, Cai Z, Jia Y, Ma Y, Zheng C, Lu Y, Roden R, Chen Y: Single walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells. Gene Ther. 2006, 13: 1714–2310. 10.1038/sj.gt.330280810.1038/sj.gt.3302808 ↗
15. Dresselhaus MS, Dresselhaus G, Avouris P: Carbon Nanotubes: Synthesis, Structure, Properties, and Applications. Heidelberg: Springer; 2001.10.1007/3-540-39947-X ↗
16. Dresselhaus MS, Dresselhaus G, Eklund PC: Science of Fullerenes and Carbon Nanostructure. San Diego: Academic Press; 1996.
17. Cuniberti G, Yi J, Porto M: Pure-carbon ring transistor: role of topology and structure. Appl. Phys. Lett. 2002, 81: 850–852. 10.1063/1.149719510.1063/1.1497195 ↗
18. Dekker C: Carbon nanotubes as molecular quantum wires. Physics Today 1999,52(5):22–28. 10.1063/1.88265810.1063/1.882658 ↗
19. Yamada T, Namail T, Hata K, Futaba DN, Mizuno K, Fan J, Yudasaka M, Yumura M, Iijima S: Size-selective growth of double-walled carbon nanotube forests from engineered iron catalysts. Nat. Nanotechnol. 2006, 1: 131–136. 10.1038/nnano.2006.9510.1038/nnano.2006.95 ↗
20. Lacerda L, Raffa S, Prato M, Bianco A, Kostarelos K: Cell-penetrating CNTs for delivery of therapeutics. Nano Today 2007, 2: 38–43.10.1016/S1748-0132(07)70172-X ↗
21. Shoeb M: Anticancer agents from medicinal plants. Bangladesh J. Pharmacol 2006, 1: 35–41.
22. Rida SM, Ashour FA, El-Hawash SAM, ElSemary MM, Badr MH, Shalaby MA: Synthesis of some novel benzoxazole derivatives as anticancer,anti-HIV-1 and antimicrobial agents. Eur. J. Med. Chem. 2005,40(9):949–959. 10.1016/j.ejmech.2005.03.02310.1016/j.ejmech.2005.03.023 ↗
23. Parish C, Szczepanska A, Espartero JL, Moreno-Vargas AJ, Carmona AT, Robina I, Remmert S: Synthesis and conformational analysis of novel trimetric maleimide cross-linking reagents. J. Org. Chem. 2007, 72: 6776–6785. 10.1021/jo070929310.1021/jo0709293 ↗
24. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E: Equations of state calculations by fast computing machines. J. Chem. Phys. 1953, 21: 1087–1091. 10.1063/1.169911410.1063/1.1699114 ↗
25. Karelson M, Tamm T, Zerner MC: Multicavity reaction field method for the solvent effect description in flexible molecular systems. J. Phys. Chem. 1993, 97: 11901–11907. 10.1021/j100148a01010.1021/j100148a010 ↗
26. Wong MA, Frisch MJ, Wiberg KB: Solvent effects: 1 mediation of electrostatic effects by solvent. J. Am. Chem. Soc. 1991, 113: 4776–4782. 10.1021/ja00013a01010.1021/ja00013a010 ↗
27. Wong MA, Frisch MJ, Wiberg KB: Solvent effects: 2 medium effect on the structure, energy, charge density, and vibrational frequencies of sulfamic acid. J. Am. Chem. Soc. 1992, 114: 523–529. 10.1021/ja00028a01910.1021/ja00028a019 ↗
28. Gelman A, Roberts GO, Gilks WR: Efficient metropolis jumping rules. In Bayesian Statistics V. Edited by: Bernardo M. Oxford: Oxford University Press; 1996:599–607.10.1093/oso/9780198523567.003.0038 ↗
29. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Petersson GA, Ayala PY, Cui Q, Morokuma K, Malick DK: Gaussian 98 Revision A.6. Pittsburgh PA: Gaussian, Inc; 1998.
30. Witanowski M, Biedrzycka Z, Sicinska W, Grabowski Z: A study of solvent polarity and Hydrogen bonding effects on the nitrogen NMR shieldings of N-nitramines and ab initio calculations of the nitrogen shieldings of C-nitro and O-nitro systems. J. Mol. Struct. 2002, 602–603: 199–207.10.1016/S0022-2860(01)00734-7 ↗
31. Mora-Diez N, Senent ML, Garcia B: Ab initio study of solvent effects on the acetohydroxamic acid deprotonation processes. Chemical Physics 2006,324(2–3):350–358.10.1016/j.chemphys.2005.10.039 ↗